Great Elm Group, Inc. (GEG) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Great Elm Group, Inc. (GEG) trades at $2.15 with AI Score 25/100 (Grade F). Great Elm Group, Inc. operates in the healthcare sector, focusing on durable medical equipment distribution and investment management. Market cap: $67.4M, Sector: Healthcare.
Price as of Jul 23, 2026 · Last analyzed: May 10, 2026Analyst Coverage for GEG: GEG does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GEG against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
GEG: 2/3 scored disciplines lean bearish. Dominant signal: Ken Griffin bearish.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Great Elm Group, Inc. (GEG) Healthcare & Pipeline Overview
Great Elm Group, Inc. (GEG) distributes durable medical equipment, including respiratory care devices, and offers investment management services. Operating within the healthcare sector, the company provides essential medical equipment and financial solutions, distinguishing itself through a dual focus on healthcare distribution and investment management.
What Is the Investment Thesis for GEG?
Great Elm Group, Inc. presents a mixed investment profile. The company's involvement in both durable medical equipment distribution and investment management provides diversification. However, the company's negative profit margin of -100.5% raises concerns about profitability. A beta of 0.53 suggests lower volatility compared to the market. Growth catalysts include potential expansion of its respiratory care equipment distribution and increased demand for investment management services. The company's small market capitalization of $67.4M indicates it is a micro-cap stock, which can be subject to higher volatility and liquidity risks. Investors should closely monitor the company's ability to improve its profit margins and capitalize on growth opportunities in its target markets.
Based on FMP financials and quantitative analysis
GEG Key Highlights
- Market capitalization of $67.4M, indicating a micro-cap stock.
- Negative profit margin of -100.5%, reflecting significant losses.
- Gross margin of 3.1%, suggesting limited profitability from sales.
- Beta of 0.53, indicating lower volatility compared to the overall market.
- No dividend yield, as the company does not currently distribute dividends.
Who Are GEG's Competitors?
What Are GEG's Key Strengths?
- Diversified business model with healthcare and investment management segments.
- Established distribution network for durable medical equipment.
- Expertise in respiratory care equipment and sleep study services.
- Long-standing presence in the market since 1994.
What Are GEG's Weaknesses?
- Negative profit margin indicates financial challenges.
- Small market capitalization increases volatility and liquidity risks.
- Reliance on specific geographic markets.
- Limited brand recognition compared to larger competitors.
What Could Drive GEG Stock Higher?
- Expansion into new geographic markets to diversify revenue streams (2027-2029).
- Strategic partnerships with healthcare providers to enhance market reach.
- Increasing demand for sleep study services due to rising awareness of sleep disorders.
- Growing assets under management (AUM) by attracting new clients and expanding service offerings within investment management.
What Are the Key Risks for GEG?
- Financial-distress signal — its Altman Z-Score of -39.83 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-38.3%) — the business is not currently generating profit on shareholder capital.
- Negative profit margin indicates financial challenges.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturns affecting investment management performance.
- Supply chain disruptions impacting the availability of medical equipment.
- Intense competition from established DME distributors and investment management firms.
What Are the Growth Opportunities for GEG?
- Expansion of Respiratory Care Equipment Distribution: The increasing prevalence of respiratory diseases, such as COPD and sleep apnea, drives demand for respiratory care equipment. Great Elm Group can expand its distribution network and product offerings to capture a larger share of this market. The global respiratory care devices market is projected to reach $30 billion by 2028, offering substantial growth potential. Timeline: Ongoing.
- Increased Demand for Sleep Study Services: The growing awareness of sleep disorders and their impact on health is increasing demand for sleep study services. Great Elm Group can expand its sleep study service offerings and partnerships with healthcare providers to capitalize on this trend. The sleep apnea diagnostics and therapeutics market is expected to reach $5 billion by 2027. Timeline: Ongoing.
- Strategic Partnerships with Healthcare Providers: Collaborating with hospitals, clinics, and home healthcare agencies can enhance Great Elm Group's market reach and service delivery. These partnerships can provide access to a broader patient base and streamline the distribution of medical equipment. Timeline: Ongoing.
- Geographic Expansion: Expanding into new geographic markets can diversify Great Elm Group's revenue streams and reduce reliance on specific regions. Identifying underserved markets with a high demand for durable medical equipment can provide significant growth opportunities. Timeline: 2027-2029.
- Investment Management Service Expansion: Growing assets under management (AUM) by attracting new clients and expanding service offerings within investment management can significantly boost revenue. Focusing on niche investment strategies and personalized client services can differentiate Great Elm Group in the competitive investment management industry. Timeline: Ongoing.
What Opportunities Does GEG Have?
- Expansion of respiratory care equipment distribution to meet growing demand.
- Increased demand for sleep study services due to rising awareness of sleep disorders.
- Strategic partnerships with healthcare providers to enhance market reach.
- Geographic expansion into underserved markets.
What Threats Does GEG Face?
- Intense competition from established DME distributors and investment management firms.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturns affecting investment management performance.
- Supply chain disruptions impacting the availability of medical equipment.
What Are GEG's Competitive Advantages?
- Established distribution network for durable medical equipment.
- Expertise in respiratory care equipment and sleep study services.
- Dual focus on healthcare and investment management provides diversification.
- Long-standing relationships with healthcare providers.
What Does GEG Do?
Great Elm Group, Inc., established in 1994 and headquartered in Waltham, Massachusetts, operates within the healthcare and financial sectors. Originally known as Great Elm Capital Group, Inc., the company rebranded in December 2020 to better reflect its diversified business model. The company's durable medical equipment (DME) segment focuses on the distribution of respiratory care equipment, including positive air pressure (PAP) devices, ventilators, oxygen equipment, and related replacement parts. Additionally, Great Elm Group provides sleep study services and rents medical equipment to cater to a broad range of patient needs. Complementing its healthcare operations, the company offers investment management services, leveraging its financial expertise to manage assets and generate returns. This dual approach allows Great Elm Group to serve both the healthcare market and the investment community, positioning it as a versatile player in its respective industries. The company aims to provide comprehensive solutions by integrating medical equipment distribution with financial management services.
What Products and Services Does GEG Offer?
- Distributes respiratory care equipment, including PAP devices and ventilators.
- Provides oxygen equipment and related replacement parts.
- Offers sleep study services to diagnose sleep disorders.
- Rents medical equipment to patients.
- Provides investment management services to clients.
- Focuses on durable medical equipment (DME) distribution.
How Does GEG Make Money?
- Generates revenue through the sale and rental of durable medical equipment.
- Earns fees from providing sleep study services.
- Manages investments for clients, earning management and performance fees.
What Industry Does GEG Operate In?
Great Elm Group, Inc. operates in the durable medical equipment (DME) distribution and investment management industries. The DME market is driven by an aging population and increasing prevalence of chronic respiratory diseases. The investment management industry is influenced by market conditions and investor sentiment. Great Elm Group's competitors include specialized DME distributors and larger investment management firms. The company's ability to differentiate itself through specialized services and efficient operations will be crucial for success in these competitive landscapes.
Who Are GEG's Key Customers?
- Patients requiring respiratory care equipment.
- Hospitals and clinics needing medical equipment.
- Individuals seeking sleep study services.
- Investors seeking investment management services.
F-Score 5/9Financial Health
Great Elm Group, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -39.83 places it in the distress zone, a signal of elevated financial risk.
ROE -38%Key Financial Metrics
Return on equity for Great Elm Group, Inc. stands at -38.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -20.5%, showing how much profit it generates from its asset base. Its free cash flow yield is 16.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 13.18 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -34.2%, the inverse of the P/E and a quick read on earnings relative to price.
Great Elm Group, Inc. (GEG) Valuation Context
Valued at $67.4M, GEG is classified as a micro-cap stock.
FY2026 estForward Outlook
Wall Street analysts project Great Elm Group, Inc. revenue of about $5.0M for fiscal 2026, with EPS near $-3.16.
GEG Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Diversified business model with healthcare and investment management segments.
- Established distribution network for durable medical equipment.
- Expertise in respiratory care equipment and sleep study services.
- Long-standing presence in the market since 1994.
Bear Case
- Negative profit margin indicates financial challenges.
- Small market capitalization increases volatility and liquidity risks.
- Reliance on specific geographic markets.
- Limited brand recognition compared to larger competitors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
GEG Latest News
No recent news available for GEG.
GEG Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GEG.
Price Targets
Wall Street price target analysis for GEG.
GEG MoonshotScore
What does this score mean?
The MoonshotScore rates GEG 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Jason W. Reese
CEO
Jason W. Reese serves as the CEO of Great Elm Group, Inc. His background includes extensive experience in investment management and corporate strategy. Prior to his role at Great Elm Group, Reese held leadership positions in various financial services firms, focusing on portfolio management and business development. He brings a wealth of knowledge in capital allocation and strategic planning to the company.
Track Record: Under Jason W. Reese's leadership, Great Elm Group, Inc. has focused on expanding its durable medical equipment distribution network and enhancing its investment management services. Key milestones include the rebranding of the company in December 2020 and efforts to improve operational efficiency. Reese has been instrumental in navigating the company through challenging market conditions and positioning it for future growth.
What Investors Ask About Great Elm Group, Inc. (GEG) — Healthcare
What does the AI Score mean for GEG?
GEG holds an AI Score of 25/100 (Grade: F). This is an educational research signal, not a buy or sell recommendation. Great Elm Group, Inc. operates in the healthcare sector, focusing on durable medical equipment distribution and investment management. The company provides respiratory care equipment and investment …
What does Great Elm Group, Inc. do?
Great Elm Group, Inc. operates in the healthcare and financial sectors, focusing on durable medical equipment (DME) distribution and investment management. The company distributes respiratory care equipment, including positive air pressure (PAP) devices, ventilators, and oxygen equipment. It also provides sleep study services and rents medical equipment.
What do analysts say about GEG stock?
Analyst coverage of Great Elm Group, Inc. (GEG) is limited due to its small market capitalization. Key valuation metrics include its market cap of $67.4M and a negative profit margin of -100.5%. Growth considerations focus on the company's ability to expand its respiratory care equipment distribution and increase assets under management in its investment management segment.
What are the main risks for GEG?
Great Elm Group, Inc. faces several risks, including its negative profit margin, which indicates financial instability. The company also faces competition from established DME distributors and investment management firms. Changes in healthcare regulations and reimbursement policies could impact its DME business. Economic downturns could affect its investment management performance. Supply chain disruptions could impact the availability of medical equipment.
What are the key factors to evaluate for GEG?
Great Elm Group, Inc. (GEG) holds an AI score of 25/100 (low). Not financial advice.
How frequently does GEG data refresh on this page?
GEG's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven GEG's recent stock price performance?
Great Elm Group, Inc. (GEG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business model with healthcare and investment management segments. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GEG overvalued or undervalued right now?
Great Elm Group, Inc. (GEG) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research GEG before investing?
Before investing in Great Elm Group, Inc. (GEG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Analyst coverage is limited due to the company's small market capitalization.